For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other antidiabetic drugs, according ...
Jul 22, 2025
0
0
New research from Karolinska Institutet demonstrates a link between inflammatory bowel disease and faster cognitive decline among dementia patients. The study, which is published in the journal Gut, indicates a need for personalized ...
Jul 22, 2025
0
63
For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) versus dipeptidyl peptidase-4 inhibitors (DPP4is), ...
Jul 22, 2025
0
0
Matthew Leming, Ph.D., and Hyungsoon Im, Ph.D. of the Center for Systems Biology at Massachusetts General Hospital, are the co-corresponding authors of a paper published in Alzheimer's & Dementia, "Differential dementia detection ...
Jul 21, 2025
0
0
In a study published in Alzheimer's & Dementia, a team led by Dr. Sha Feng from the Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences—collaborating with Dr. Jed A. Barash from the Massachusetts ...
Jul 21, 2025
0
0
Scientists know that many proteins and pathways are involved in the development and progression of neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease and frontotemporal dementia (FTD), and that ...
Jul 21, 2025
0
30
The Global Neurodegeneration Proteomics Consortium (GNPC) has published a series of research papers detailing their efforts to identify patterns in neurodegenerative disease. Sifting through roughly 250 million plasma measurements, ...
The term dementia is used to describe various debilitating neurological disorders characterized by a progressive loss of memory and a decline in mental abilities. Estimates suggest that over 55 million people worldwide are ...
Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They found that the drug slowed cognitive decline by 46% in a group of patients with early-stage, slow-progressing ...
Jul 17, 2025
0
31
A new treatment that uses music therapy on dementia wards could improve care and support for some of the NHS's most vulnerable patients.
Jul 16, 2025
0
0
